Indications for and Experience With the Wearable Cardioverter Defibrillator (WCD) - Austrian WCD Registry
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 450
- 试验地点
- 1
- 主要终点
- Number of participants treated with WCD-treated ventricular arrhythmias
研究概览
简要总结
Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI <40days, recent PCI/CABG < 3months etc.).
Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.
详细描述
Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients, with a prescribed WCD according to guidelines in an austrian center
排除标准
- 未提供
结局指标
主要结局
Number of participants treated with WCD-treated ventricular arrhythmias
时间窗: during WCD wearing period; average of 1 year
Number of participants treated with WCD-treated ventricular arrhythmias
次要结局
未报告次要终点
研究者
Scherr Daniel, MD
Austrian Wearable Cardioverter Defibrillator Registry
Medical University of Graz